EPISODE · May 28, 2024 · 22 MIN
Episode 36: Idiopathic Pulmonary Fibrosis Research with Key Opinion Leader Victor Thannickal
from BIO from the BAYOU: Build Your Biotech Network with Key Opinion Leaders and Investors
Idiopathic Pulmonary Fibrosis (IPF) is a devastating lung disease affecting millions worldwide, with a grim prognosis of only three to five years post-diagnosis. In this episode, leading lung disease expert Victor Thannickal, MD, delves into the symptoms, progression, and impacts of IPF. He also sheds light on promising new drug therapies emerging from his lab, offering hope in the fight against this relentless disease. Host Elaine Hamm, PhD, skillfully navigates the complex landscape of IPF, making this a must-listen for anyone interested in cutting-edge biotech developments. If you enjoyed the episode, please consider liking, sharing, and subscribing to BIO from the BAYOU. Your support helps us continue delivering high-quality content to listeners passionate about the biotech industry. Links: Connect with Victor Thannickal, MD. Check out the Tulane Medicine Magazine, which provides more details on Tulane’s fight against IPF. Connect with Elaine Hamm, PhD. Learn about Tulane Medicine Business Development and the School of Medicine. Check out BIO on the BAYOU and make plans to attend October 29 & 30, 2024. Learn more about BIO from the BAYOU – the podcast, the upcoming event, and more! Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
What this episode covers
Idiopathic Pulmonary Fibrosis (IPF) is a devastating lung disease affecting millions worldwide, with a grim prognosis of only three to five years post-diagnosis. In this episode, leading lung disease expert Victor Thannickal, MD, delves into the symptoms, progression, and impacts of IPF. He also sheds light on promising new drug therapies emerging from his lab, offering hope in the fight against this relentless disease. Host Elaine Hamm, PhD, skillfully navigates the complex landscape of IPF, making this a must-listen for anyone interested in cutting-edge biotech developments. If you enjoyed the episode, please consider liking, sharing, and subscribing to BIO from the BAYOU. Your support helps us continue delivering high-quality content to listeners passionate about the biotech industry. Links: Connect with Victor Thannickal, MD. Check out the Tulane Medicine Magazine, which provides more details on Tulane’s fight against IPF. Connect with Elaine Hamm, PhD. Learn about Tulane Medicine Business Development and the School of Medicine. Check out BIO on the BAYOU and make plans to attend October 29 & 30, 2024. Learn more about BIO from the BAYOU – the podcast, the upcoming event, and more! Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
NOW PLAYING
Episode 36: Idiopathic Pulmonary Fibrosis Research with Key Opinion Leader Victor Thannickal
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.